A Phase 4 interventional study of Lansoprazole in Gastroesophageal Reflux, sponsored by Osaka University. Withdrawn at 1 site in Japan. Open to participants aged 1 Year to 15 Years. Per ClinicalTrials.gov, last updated 2012-10-11.
Sponsored by Osaka University · Phase 4, Interventional, and Treatment
Proton pump inhibitors are administered to children as off-label use in Japan. The purpose of this study is to evaluate the effects of CYP2C19 genotypes on pharmacokinetic /pharmacodynamic profiles of PPI in children. The results will provide the beneficial information for the individualized medicine of PPI in children.
1,067 studies on the registry are indexed under Gastroesophageal Reflux; 188 are open to participants now.
Browse Gastroesophageal Reflux studies →Osaka University is the lead sponsor of 33 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
This study is withdrawn, as verified in Sep 2006. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Osaka University